IDT Appoints William Conkling to Board of Directors as New Audit Chair

IDT Corporation announced changes to its Board of Directors, appointing William Conkling as a new independent director, effective June 9, 2026. The appointment follows the resignation of director Irwin Katsof on the same day.

Key Details

• New Director: William Conkling was appointed to the Board. He is the current Chief Commercial Officer of Protara Therapeutics and former CEO of Rafael Holdings.
• Committee Leadership: Mr. Conkling is expected to serve as the Chairman of the Audit Committee and be designated as the Audit Committee Financial Expert.
• Director Resignation: The appointment follows the resignation of Irwin Katsof, effective June 9, 2026. The company noted the resignation was not the result of any disagreement with company operations or policies.